Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Xinfa Pharmaceutical Co., Ltd
EIR
•Xinfa Pharmaceutical Co., Ltd•April 7, 2016

Xinfa Pharmaceutical Co., Ltd – FDA EIR, Apr 7, 2016

Record Details

An FDA inspection of Xinfa Pharmaceutical Co., Ltd in Dongying, China, was conducted from April 5-7, 2016, focusing on the company's manufacturing of dietary supplement and animal feed ingredients like Riboflavin. The inspection evaluated compliance with domestic food safety regulations and Good Manufacturing Practices (GMPs).

The inspection resulted in a Form FDA 483, Inspectional Observations, issued to owner Mr. Xinfa Li. Key violations included a failure to adequately clean and sanitize food-contact surfaces, specifically Riboflavin tanks, filters, and sieves, which showed product residue even after cleaning and quality control release. Additionally, the inspection noted inadequate lighting in manufacturing areas, particularly in the Riboflavin workshop, hindering proper assessment of equipment conditions.

Verbal deficiencies also highlighted issues such as insufficient hand-washing facilities (which were corrected during the inspection), unscreened gaps in warehouse doors, and harborage areas with unused equipment and uncovered garbage bins (corrections in progress). Mr. Li acknowledged the findings and committed to implementing corrective actions. He also agreed to provide a written response to the FDA 483 observations within 15 business days. The FDA investigator also offered recommendations for improving the Certificate of Analysis, implementing continuous temperature and humidity monitoring, maintaining legible records, and utilizing the most current USP methods for laboratory testing.

Company
Xinfa Pharmaceutical Co., Ltd
Inspection date
April 7, 2016
Product type
Dietary Supplements
Office
Office of Regulatory Affairs
Person
  • Rachel A. Gomez (investigator)
View Company Profile

ID · f003c610-c87c-4e3f-b80b-fa8c3e99dde4

Violation Codes2
21 CFR 110.35(a)21 CFR 110.20(b)(5)

Full citation text and observation details available on the Dashboard.

Other documents for Xinfa Pharmaceutical Co., Ltd
  • 483 - 2016-04-05April 5, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Xinfa Pharmaceutical Co., Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.